
BRNS
Healthcare · Biotechnology · $30.2M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +10.3% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 6, 2026 | Before the open | -0.28 | -0.26 | +7.1% |
| Apr 30, 2026 | Before the open | -0.28 | -0.14 | +50.0% |
| Mar 20, 2026 | Time not confirmed | -0.39 | -0.27 | +29.8% |
| Nov 7, 2025 | Before the open | -0.39 | -0.24 | +38.5% |
| Aug 7, 2025 | Before the open | -0.29 | -0.52 | -79.3% |
| May 7, 2025 | Before the open | -0.36 | -0.49 | -36.1% |
| Mar 18, 2025 | Before the open | -0.37 | -0.20 | +45.4% |
| Nov 6, 2024 | Before the open | -0.44 | -0.21 | +52.3% |
| Aug 8, 2024 | Before the open | -0.41 | -0.43 | -4.9% |
| May 13, 2024 | Before the open | -0.61 | -0.40 | +34.4% |
| Mar 20, 2024 | Before the open | -0.50 | -0.45 | +10.0% |
| Nov 9, 2023 | After the close | -0.55 | -0.37 | +32.7% |
| Aug 10, 2023 | Before the open | -0.59 | -0.62 |
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease; and VTP-300, an…
| -5.1% |
| May 12, 2023 | Before the open | -0.58 | -0.48 | +17.2% |
| Mar 24, 2023 | Before the open | -0.42 | -0.57 | -35.7% |
| Nov 10, 2022 | After the close | -0.52 | 0.22 | +142.3% |
| Aug 9, 2022 | After the close | -0.40 | 0.43 | +207.5% |
| May 11, 2022 | After the close | -0.31 | 0.07 | +122.6% |
| Mar 25, 2022 | Before the open | -0.58 | -0.38 | +34.5% |
| Nov 12, 2021 | Before the open | -0.30 | -0.13 | +56.7% |
| Aug 12, 2021 | Before the open | -0.59 | -0.64 | -8.5% |
| Apr 30, 2021 | Before the open | -2.11 | -1.90 | +10.0% |